GlassScriptPhysician profile
Elizabeth Bostic
NPI 1962097154
$641.08
in general payments reported to CMS, 2019-2025
17 companies · $31.93 in 2025
The $31.93 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $74.13 · 2022: $384 · 2023: $124 · 2024: $27.21 · 2025: $31.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $183.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $121.31 | 2021-2024 | Trintellix |
| Bayer Healthcare Pharmaceuticals INC. | $101.85 | 2022-2024 | |
| Amgen INC. | $69.33 | 2022-2025 | Otezla, Repatha, Repatha |
| Daiichi Sankyo INC. | $62.19 | 2022 | |
| Esperion Therapeutics, INC. | $46.06 | 2021 | |
| Lilly USA, LLC | $40.44 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $39.52 | 2023 | Xifaxan |
| Abbvie INC. | $25.32 | 2023 | |
| Novartis Pharmaceuticals Corporation | $17.77 | 2023 | |
| Sanofi-Aventis U.S. LLC | $17.27 | 2022 | |
| Corcept Therapeutics | $16.73 | 2025 | Korlym |
| Amarin Pharma, INC. | $14.91 | 2022 | |
| Seqirus USA INC | $14.40 | 2022 | |
| Medtronic, INC. | $13.83 | 2021 | |
| Idorsia Pharmaceuticals US INC | $13.63 | 2023 | Quviviq |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $13.33 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $13.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Bostic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.